Medicare fee-for-service (FFS) - physician fee schedule (PFS)/outpatient prospective payment system (opps) and medicare advantage (part c)/ prescription drug (part d) public comment support

Active Awarded Last action

Contract number
75FCMC22F0040
Awardee
Awarding agency
Obligated
$9,404,386

Award facts

Contract value 74% obligated
  • $9,404,386.00 Current, with exercised options
  • $12,625,933.00 Potential, with all options
Completion date 88% complete
Current and potential, with all options
Set-aside
Woman-Owned Small Business Sole Source
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Washington, DC 20009, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00015 · EO 14398, addressing DEI discrimination by federal contractors $1,155,874
Other Administrative Action P00014 $0
Exercise an Option P00013 $1,465,401
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Exercise an Option P00008 $1,434,830
Other Administrative Action P00007 $0
Exercise an Option P00006 $1,806,385
Other Administrative Action P00005 $0
Supplemental Agreement for work within scope P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $3,541,896
Show all 16

About this award

The Centers for Medicare and Medicaid Services issued a delivery order to L&M Policy Research, LLC, a woman-owned small business, on June 1, 2022, with a ceiling value of $12.6 million under a Multiple Award Schedule (MAS) contract for Medicare fee-for-service and Medicare Advantage public comment support services.

The delivery order, issued under a woman-owned small business sole source set-aside, supports public comment activities for the Medicare Physician Fee Schedule, Outpatient Prospective Payment System, and Medicare Advantage and Prescription Drug plan policies. Work is performed in Washington, DC, with an ultimate completion date of May 31, 2027. Pricing is time and materials. The scope includes healthcare policy research and consulting services supporting CMS program evaluation and beneficiary engagement initiatives.

Quick answers

Who was awarded contract 75FCMC22F0040?

75FCMC22F0040 was awarded to L&M Policy Research, LLC by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on June 1, 2022.

How much is contract 75FCMC22F0040 worth?

The government has obligated $9,404,386 on 75FCMC22F0040. Its potential value, with all options, is $12,625,933.

Is contract 75FCMC22F0040 an order under another contract?

Yes. 75FCMC22F0040 is a delivery order under 47QRAA20D0072, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75FCMC22F0040 competed?

The extent of competition for 75FCMC22F0040 was full and open competition. The government received 1 offer. It was set aside: Woman-Owned Small Business Sole Source.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award